-
Neticonazole Hydrochloride: Research Workflows
2026-09-30
Neticonazole Hydrochloride supports a practical antifungal workflow and an exploratory oncology workflow centered on exosome inhibition in cancer. This guide connects direct Candida diagnostics, controlled cell assays, Bcl-2/Bax readouts, and troubleshooting strategies without overstating the maturity of the colorectal cancer evidence.
-
G-1: Selective GPR30 Agonist Workflows
2026-09-30
G-1 enables researchers to isolate GPR30 signaling from classical estrogen-receptor activity in calcium, migration, cardiac, and neural assays. This practical guide connects product properties with concentration planning, cell-type-specific controls, reference-study insights, and troubleshooting strategies.
-
Masitinib (AB1010): Practical Research Workflow
2026-09-29
Masitinib (AB1010), SKU A2942, is a DMSO-compatible research inhibitor for controlled studies of KIT, PDGFRα, PDGFRβ, KIT-mutant cells, and mast-cell responses. It is appropriate for targeted cancer and mastocytosis research, but not for aqueous or ethanol-based assays, broad-spectrum kinase profiling, or clinical treatment decisions.
-
Sucrose in Freeze-Dried mRNA-LNP Formulations
2026-09-29
Sucrose can do more than protect biomolecules during drying: it can help preserve the physical integrity and functional performance of mRNA–lipid nanoparticles. This article translates recent drying science into practical formulation, process, and analytical decisions for sucrose-containing nucleic acid products.
-
Insulin–AMPK Control of Pink1 mRNA in Neurons
2026-09-28
A neuronal preprint proposes that insulin signaling regulates mitochondrial Pink1 mRNA localization by inhibiting AMPK, which otherwise supports the RNA-anchoring interaction between SYNJ2BP and SYNJ2. The findings connect this localization switch to PINK1 activity and suggest that insulin resistance, including an APOE4-associated model, may impair mitochondrial quality control in neurites.
-
ONX-0914 (PR-957) Assay Design Guide
2026-09-27
This scenario-driven guide explains how to use ONX-0914 (PR-957), SKU A4011, to investigate LMP7-dependent immune modulation without confusing target engagement with cell viability. It covers assay controls, compound handling, interpretation, and evidence-based supplier selection.
-
p-Cresyl Sulfate at the Gut–Liver–Kidney Interface
2026-09-26
p-Cresyl sulfate is best understood as more than a uremic cardiovascular research tool: emerging evidence links this gut-derived metabolite to biliary epithelial injury. This article examines the evidence, its limits, and how to design interpretable hepatobiliary experiments.
-
Silymarin Research with Silybin A
2026-09-26
Use defined Silybin A to probe oxidative stress, inflammatory signaling, and liver-cell responses without treating a complex Silymarin mixture as a single compound. A practical workflow connects these assays to adipose-targeted Fabp4 CRISPRi research while keeping the evidence and limitations distinct.
-
PET Tracking of mRNA Vaccine Antigen Expression
2026-09-25
Blizard and colleagues developed a PET/CT reporter approach that links expression of an mRNA-encoded antigen to an eDHFR tag and a radiolabeled trimethoprim tracer. In mice and non-human primates, the method visualized where antigen expression occurred and how it changed over time, offering a readout distinct from tracking a vaccine’s delivery vehicle or mRNA alone.
-
Nuclear cGAS Restricts LINE-1 Retrotransposition
2026-09-25
The study shows that nuclear cGAS suppresses LINE-1 retrotransposition by helping the E3 ligase TRIM41 ubiquitinate and destabilize the L1 protein ORF2p. DNA damage-induced CHK2 phosphorylation strengthens this regulatory axis, connecting genome surveillance to post-translational control of a mobile genetic element.
-
Gepotidacin: From Enzyme Inhibition to Exposure Design
2026-09-24
Gepotidacin (GSK2140944) offers a distinct way to interrogate bacterial DNA replication and topoisomerase inhibition. This article connects its in vitro activity with human pharmacokinetic findings to help researchers design more interpretable, exposure-aware antibacterial studies.
-
DiD (DiDC 18 (5)) for Membrane Tracking
2026-09-24
DiD (DiDC 18 (5)) is a red fluorescent lipophilic probe for plasma-membrane labeling and cell tracking. This article distinguishes its documented staining properties from its potential use in diabetic-periodontitis research, where the cited therapeutic study did not report using DiD.
-
Calpain, BDNF/TrkB, and Offspring Cognition
2026-09-23
The reference study identifies excessive calpain activity as a mechanistic link between maternal non-obstetric surgery during pregnancy and later offspring cognitive impairment. Using behavioral, structural, and molecular endpoints, it shows that calpain inhibition or TrkB activation partially restores hippocampal synaptic and neuronal abnormalities.
-
GSK126 EZH2 Inhibitor: Applied Research Guide
2026-09-23
GSK126 gives researchers a controllable way to test how PRC2-dependent H3K27me3 supports gene silencing, tumor growth, and treatment response. This practical guide connects dose–time design, chromatin readouts, cancer models, and the reference study’s FMR1-reactivation strategy while clearly separating validated evidence from assay recommendations.
-
TP–CTGF Signaling Drives Nasal Fibroblast Migration
2026-09-22
The reference study identifies thromboxane prostanoid receptor activation as an upstream signal that induces CTGF and promotes human nasal fibroblast migration through NF-κB and PKCδ–CREB pathways. Its combination of pharmacological stimulation, pathway perturbation, gene silencing, and motility assays distinguishes a receptor-specific remodeling mechanism from nonspecific phorbol ester signaling.